IMU 4.35% 4.4¢ imugene limited

Media Thread, page-15784

  1. 6,100 Posts.
    lightbulb Created with Sketch. 1966
    " so the company must presumably be seeing some positive
    outcomes to continue with the cost?? "

    LOL thats a bit of an understatement I reckon .

    I guess so many holders are a bit bamboozled as to what constitutes a good announcement , as the R & D work that IMU are doing is pretty cutting edge ...and there are so many steps of progression ....

    Setting aside the disappointment as where the current share price is , any body who doesn't think IMU are making stellar progress on a number of fronts ...likely just doesn't understand how these these things work ... or is .... ( I'll be tactful .... but will leave it to others to fill in the gap ............ )

    Its a bit like a mineral explorations company ...reporting indicative chemistry in the geology of an area they might be pospecting .... ( means zippo to most ...but could mean something very significant some time down the track )

    I just lifted a couple of pages off the ASX website .... and I'd say there are some very very significant announcements there .... but most fall on deaf ears unfortunately , and I couldn't be rooted trying to explain each one .... .

    Look to Davey for those very interesting explanations and analysis ...he is just so generous with his time and input .

    Better still spend some time on the website .... its a wealth of info

    cheers to all including all the non believers ....

    LOL




    Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7 Column 8
    0 30 Sep 20245:01pm 5:01pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Change of Director's Interest Notice - PH opens new window256KB 256KB
    • Change of Director's Interest Notice
    1 18 Sep 20241:06pm 1:06pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes Imugene Receives Orphan Drug Designation for VAXINIA opens new window237KB 237KB
    • Progress Report
    2 11 Sep 20244:59pm 4:59pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Appendix 2A opens new window435KB 435KB
    • Appendix 2A
    3 9 Sep 202410:12am 10:12am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Imugene Corporate Presentation opens new window3657KB 3657KB
    • Company Presentation
    4 4 Sep 20244:32pm 4:32pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Cleansing Notice opens new window198KB 198KB
    • Cleansing Notice
    5 4 Sep 20244:29pm 4:29pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Application for quotation of securities - IMU opens new window17KB 17KB
    • Appendix 2A
    6 4 Sep 202410:19am 10:19am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Imugene Azer-cel Webinar Presentation opens new window1405KB 1405KB
    • Company Presentation
    7 3 Sep 20248:26am 8:26am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Imugene Webinar - Azer-cel Trial Update opens new window211KB 211KB
    • Web Cast
    8 2 Sep 20248:44am 8:44am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes Three Complete Responses in Azer-Cel Phase 1b Trial opens new window319KB 319KB
    • Progress Report
    9 30 Aug 20246:44pm 6:44pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Imugene ESG Report 2024 opens new window2840KB 2840KB
    • Periodic Reports - Other
    10 30 Aug 20246:43pm 6:43pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Corporate Governance Statement 2024 and Appendix 4G opens new window671KB 671KB
    • Corporate Governance and 1 more
    11 30 Aug 20246:43pm 6:43pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes Appendix 4E and Annual Report opens new window5710KB 5710KB
    • Annual Report and 6 more
    12 2 Aug 20245:59pm 5:59pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Release of Shares from Voluntary Escrow opens new window130KB 130KB
    • Issued Capital - Other
    13 31 Jul 20249:16am 9:16am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes Quarterly Activities/Appendix 4C Cash Flow Report opens new window458KB 458KB
    • Commitments Test Entity - Fourth Quarter Activity Report and 1 more
    14 12 Jul 20245:28pm 5:28pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Notification of cessation of securities - IMU opens new window16KB 16KB
    • Appendix 3H (Notification of cessation of securities)
    15 12 Jul 20245:19pm 5:19pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Notification regarding unquoted securities - IMU opens new window19KB 19KB
    • Appendix 3G
    16 10 Jul 20249:20am 9:20am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes First patient dosed in Phase 1 bile tract cancer trial opens new window368KB 368KB
    • Progress Report
    17 8 Jul 20244:50pm 4:50pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Change of Director's Interest Notice x6 opens new window49KB 49KB
    • Change of Director's Interest Notice
    18 8 Jul 202411:20am 11:20am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Application for quotation of securities - IMU opens new window22KB 22KB
    • Appendix 2A
    19 4 Jul 20243:44pm 3:44pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Imugene Corporate Presentation opens new window2106KB 2106KB
    • Company Presentation
    20 24 Jun 20248:24am 8:24am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes Imugene onCARlytics Doses First Patient in IV Combination opens new window169KB 169KB
    • Progress Report
    21 30 May 202412:06pm 12:06pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Imugene Presentation to Bell Potter Conference opens new window1802KB 1802KB
    • Company Presentation
    22 6 May 20244:10pm 4:10pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Application for quotation of securities - IMU opens new window17KB 17KB
    • Appendix 2A
    23 30 Apr 20248:48am 8:48am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes Quarterly Activities/Appendix 4C Cash Flow Report opens new window484KB 484KB
    • Commitments Test Entity - Third Quarter Activity Report and 1 more
    24 23 Apr 20244:50pm 4:50pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Change of Director's Interest Notice - PH opens new window4KB 4KB
    • Change of Director's Interest Notice


    Go look for your self for the missing ones .... LOL


    {caption}Announcments results{/caption}
    1 DATE /TIME TIME CODE /COMPANY NAME COMPANY NAME PRICE SENSITIVEPRICESENSITIVE HEADLINE /DOC SIZE DOC SIZE TYPE
    2 17 Jan 20249:39am 9:39am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Notification regarding unquoted securities - IMU opens new window40KB 40KB
    • Appendix 3G
    3 10 Jan 202410:58am 10:58am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Imugene Presentation to JPMorgan Healthcare Conference opens new window4438KB 4438KB
    • Company Presentation
    4 12 Dec 20239:28am 9:28am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes Imugene and NeoImmuneTech to Improve Cancer Treatments opens new window193KB 193KB
    • Progress Report
    5 11 Dec 20239:01am 9:01am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Imugene to Present at Annual JPMorgan Healthcare Conference opens new window164KB 164KB
    • Web Cast
    6 6 Dec 20236:32pm 6:32pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Application for quotation of securities - IMU opens new window26KB 26KB
    • Appendix 2A
    7 6 Dec 20239:31am 9:31am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes New PD1-Vaxx Phase 2 CRC Cancer Trial to Open in UK and AUS opens new window176KB 176KB
    • Progress Report
    8 6 Dec 20238:50am 8:50am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes Europe Patent to be Granted for PD1-Vaxx Cancer Vaccine opens new window127KB 127KB
    • Progress Report
    9 30 Nov 20235:30pm 5:30pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Results of Meeting opens new window191KB 191KB
    • Results of Meeting
    10 30 Nov 20232:03pm 2:03pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no AGM Presentation opens new window3099KB 3099KB
    • Company Presentation and 1 more
    11 28 Nov 20238:53am 8:53am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes FDA Fast Track Designation Granted for VAXINIA Trial Program opens new window161KB 161KB
    • Progress Report
    12 14 Nov 20234:38pm 4:38pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Investor Webinar featuring COO, Dr Glover & CMO, Dr Woodard opens new window119KB 119KB
    • Web Cast
    13 10 Nov 20239:03am 9:03am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes Azer-cel Hits Major Milestone in Phase 1b CAR T Trial opens new window193KB 193KB
    • Progress Report
    14 7 Nov 20231:05pm 1:05pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Imugene Investor Webinar - MAST Study Update opens new window119KB 119KB
    • Web Cast
    15 6 Nov 20239:54am 9:54am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes Phase 1 CF33 VAXINIA Study Update - Positive Early Signals opens new window179KB 179KB
    • Progress Report
    16 2 Nov 20239:39am 9:39am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes Next cohort reached in IV arms of CF33-hNIS (VAXINIA) study opens new window174KB 174KB
    • Progress Report
    17 31 Oct 20236:19pm 6:19pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Amended Annual Report opens new window4292KB 4292KB
    • Annual Report and 5 more
    18 31 Oct 20239:05am 9:05am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes Quarterly Activities/Appendix 4C Cash Flow Report opens new window488KB 488KB
    • Commitments Test Entity - First Quarter Activity Report and 1 more
    19 30 Oct 20237:00pm 7:00pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Notice of Annual General Meeting/Proxy Form opens new window1073KB 1073KB
    • Notice of Annual General Meeting and 1 more
    20 26 Oct 20239:08am 9:08am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes Imugene Phase 1 onCARlytics CD19 virus clinical trial opens opens new window148KB 148KB
    • Progress Report
    21 24 Oct 20239:44am 9:44am
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED yes Imugene B Cell & OV Platforms Featured at ESMO Congress opens new window172KB 172KB
    • Progress Report
    22 12 Oct 20236:01pm 6:01pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Change of Director's Interest Notice - PH opens new window5KB 5KB
    • Change of Director's Interest Notice
    23 11 Oct 20237:39pm 7:39pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Change of Director's Interest Notice - LC opens new window8KB 8KB
    • Change of Director's Interest Notice
    24 4 Oct 20237:25pm 7:25pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Change of Director's Interest Notice - PH opens new window5KB 5KB
    • Change of Director's Interest Notice
    25 4 Oct 20237:18pm 7:18pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Change of Director's Interest Notice - JD opens new window4KB 4KB
    • Change of Director's Interest Notice
    26 4 Oct 20237:17pm 7:17pm
    • IMU
    IMUGENE LIMITED
    IMUGENE LIMITED no Change of Director's Interest Notice - JE opens new window4KB 4KB
    • Change of Director's Interest Notice

    Page 3
    51 to- 75 of 1,049 results
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
4.4¢
Change
-0.002(4.35%)
Mkt cap ! $327.2M
Open High Low Value Volume
4.6¢ 4.6¢ 4.3¢ $1.410M 31.79M

Buyers (Bids)

No. Vol. Price($)
40 4222156 4.3¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 2208592 2
View Market Depth
Last trade - 16.10pm 14/11/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.